Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Saxton

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|September 1, 1984
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patientsT Tai, L D Cahan, J C Paulson, et al.
International Journal of Cancer|March 15, 1978
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patientsR E Saxton, R F Irie, S Ferrone, et al.
The Laryngoscope|August 1, 1994
Dose response of human tumor cells to rhodamine 123 and laser phototherapyR E Saxton, S Haghighat, D Plant, et al.
Oncology|January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteineH Takeyama, D S Hoon, R E Saxton, et al.
The Laryngoscope|May 1, 1987
Rhodamine-123 as a new photochemosensitizing agent with the argon laser: "nonthermal" and thermal effects on human squamous carcinoma cells in vitroD J Castro, R E Saxton, H R Fetterman, et al.
Journal of Clinical Laser Medicine & Surgery|April 1, 1992
Rhodamine-123 as a new chemosensitizing versus toxic agent on human squamous carcinoma cells and fibroblast culturesD J Castro, R E Saxton, H R Fetterman, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1987
Rhodamine 123 as a chemosensitizing agent for argon laser therapy. A new technique for treatment of superficial malignanciesD J Castro, R E Saxton, H R Fetterman, et al.
The Laryngoscope|April 1, 1988
Phototherapy with the argon laser on human melanoma cells "sensitized" with rhodamine-123: a new method for tumor growth inhibitionD J Castro, R E Saxton, H R Fetterman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1988
Phototherapy with argon lasers and Rhodamine-123 for tumor eradicationD J Castro, R E Saxton, H R Fetterman, et al.
The Laryngoscope|January 1, 1988
Biostimulation of human carcinoma cells with the argon laser: a previously unreported potential iatrogenic effect of lasersD J Castro, R E Saxton, H R Fetterman, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|September 1, 1984
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patientsT Tai, L D Cahan, J C Paulson, et al.
International Journal of Cancer|March 15, 1978
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patientsR E Saxton, R F Irie, S Ferrone, et al.
The Laryngoscope|August 1, 1994
Dose response of human tumor cells to rhodamine 123 and laser phototherapyR E Saxton, S Haghighat, D Plant, et al.
Oncology|January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteineH Takeyama, D S Hoon, R E Saxton, et al.
The Laryngoscope|May 1, 1987
Rhodamine-123 as a new photochemosensitizing agent with the argon laser: "nonthermal" and thermal effects on human squamous carcinoma cells in vitroD J Castro, R E Saxton, H R Fetterman, et al.
Journal of Clinical Laser Medicine & Surgery|April 1, 1992
Rhodamine-123 as a new chemosensitizing versus toxic agent on human squamous carcinoma cells and fibroblast culturesD J Castro, R E Saxton, H R Fetterman, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1987
Rhodamine 123 as a chemosensitizing agent for argon laser therapy. A new technique for treatment of superficial malignanciesD J Castro, R E Saxton, H R Fetterman, et al.
The Laryngoscope|April 1, 1988
Phototherapy with the argon laser on human melanoma cells "sensitized" with rhodamine-123: a new method for tumor growth inhibitionD J Castro, R E Saxton, H R Fetterman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1988
Phototherapy with argon lasers and Rhodamine-123 for tumor eradicationD J Castro, R E Saxton, H R Fetterman, et al.
The Laryngoscope|January 1, 1988
Biostimulation of human carcinoma cells with the argon laser: a previously unreported potential iatrogenic effect of lasersD J Castro, R E Saxton, H R Fetterman, et al.
Pageof 9